CMS vs LCTX · P/E 20, $22.42B cap vs rev $9.5M
CMS Energy Corporation (CMS) versus Lineage Cell Therapeutics Inc (LCTX) — a side-by-side from cached financials, not a winner call.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
CMS does not have a complete income-statement cache yet.
Latest reported LCTX revenue for 2024-12-31 was $9.5M. Net income was -$18.6M. Revenue was up 354.9% from 2023-12-31 to 2024-12-31. LCTX currently screens at market cap $213.6M.
CMS currently screens at market cap $22.42B and trailing P/E 20.1. LCTX currently screens at market cap $213.6M.
Not investment advice. Open the CMS and LCTX stock pages for the full models.
Not investment advice.